- Home
- ALBT vs PRFX Comparison
ALBT vs PRFX Comparison
Compare ALBT & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALBT
- PRFX
- Stock Information
- Founded
- ALBT 2014
- PRFX 2007
- Country
- ALBT United States
- PRFX Israel
- Employees
- ALBT N/A
- PRFX N/A
- Industry
- ALBT Biotechnology: Biological Products (No Diagnostic Substances)
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- ALBT Health Care
- PRFX Health Care
- Exchange
- ALBT Nasdaq
- PRFX Nasdaq
- Market Cap
- ALBT 3.1M
- PRFX 3.0M
- IPO Year
- ALBT N/A
- PRFX 2020
- Fundamental
- Price
- ALBT $5.42
- PRFX $3.16
- Analyst Decision
- ALBT
- PRFX Hold
- Analyst Count
- ALBT 0
- PRFX 1
- Target Price
- ALBT N/A
- PRFX N/A
- AVG Volume (30 Days)
- ALBT 27.1K
- PRFX 3.2M
- Earning Date
- ALBT 04-14-2025
- PRFX 01-01-0001
- Dividend Yield
- ALBT N/A
- PRFX N/A
- EPS Growth
- ALBT N/A
- PRFX N/A
- EPS
- ALBT N/A
- PRFX N/A
- Revenue
- ALBT N/A
- PRFX N/A
- Revenue This Year
- ALBT N/A
- PRFX N/A
- Revenue Next Year
- ALBT N/A
- PRFX N/A
- P/E Ratio
- ALBT N/A
- PRFX N/A
- Revenue Growth
- ALBT N/A
- PRFX N/A
- 52 Week Low
- ALBT $2.11
- PRFX $0.43
- 52 Week High
- ALBT $21.60
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- ALBT 78.62
- PRFX 49.34
- Support Level
- ALBT $3.33
- PRFX $3.22
- Resistance Level
- ALBT $3.73
- PRFX $5.47
- Average True Range (ATR)
- ALBT 0.35
- PRFX 0.34
- MACD
- ALBT 0.19
- PRFX 0.04
- Stochastic Oscillator
- ALBT 91.63
- PRFX 15.97
About ALBT Avalon GloboCare Corp.
Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment which is the key revenue driver; medical-related consulting services segment. It focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.